There is increasing evidence that EZH2 promotes angiogenesis in clear renal cell carcinoma, inflammatory breast cancer, nasopharyngeal carcinoma (NPC) and glioblastomas (GBM) [13, 40, 57]. The gene discussed is EZH2; the disease is clear cell renal carcinoma.